Medline Inc.

MDLN Healthcare Medical Instruments & Supplies

Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.

Revenue
+14.1%
Free cash flow
+916.1%
Total debt
−23.7%

Quarter to September 2026, against a year earlier

39.07 0.69 −1.74%
Market cap
$52.3B
P/E
58.4×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
2.25
Beneish M
−2.38
Dividend safety
n/a

Medline Inc. 10-Q filed Nov 4, 2026

Fiscal Q3 2026 · Period ended Sep 26, 2026 · Filed · accepted 4:32 PM ET · Document on sec.gov · Filing index

What changed

Part II, Item 1A, Risk Factors, against the 10-Q filed Aug 5, 2026: no material changes, the filing says